![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Actavis Introduces Two New Products in Turkey
Actavis Introduces Two New Products in Turkey
October 1, 2007
Actavis has launched its isotretinoin product under the brand name Zoretanin in Turkey.
Zoretanin, a treatment for severe acne, is the only generic isotretinoin available in Turkey, according to Actavis.
The product became available Sept. 19 in 10- and 20-mg capsules, the company said.
The company also launched a generic version of glimepiride, originally released by Aventis Pharma under the brand name Amaryl to treat Type 2 diabetes. The Actavis brand name in Turkey is Diaglin.
The product is available in 1-, 2-, 3- and 4-mg tablets, Actavis added.
Upcoming Events
-
21Oct